Co-targeting distinct hallmark capabilities for therapeutic benefit in pre-clinical GBM models

Chryplewicz, AgnieszkaHanahan, Douglas2021-09-112021-09-112021-09-112021-07-0110.1158/1538-7445.AM2021-1652https://infoscience.epfl.ch/handle/20.500.14299/181206WOS:000680263504410OncologyCo-targeting distinct hallmark capabilities for therapeutic benefit in pre-clinical GBM modelstext::conference output::conference proceedings::conference paper